Live Breaking News & Updates on Louisa Perreault

Stay updated with breaking news from Louisa perreault. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Monoclonal antibodies can prevent COVID-19—but successful vaccines complicate their future


Science’
s COVID-19 reporting is supported by the Pulitzer Center and the Heising-Simons Foundation.
A study in U.S. nursing homes has shown for the first time that monoclonal antibodies, mass-produced in a laboratory, can protect people from developing symptomatic COVID-19. Their manufacturer, Eli Lilly, hopes these antibodies will provide an additional way to protect people at risk of serious disease from the pandemic coronavirus. But given the success of COVID-19 vaccines and their increasing availability, it’s not clear that the expensive and somewhat cumbersome intervention will be widely used.
Both Eli Lilly’s monoclonal antibody and a similar two-antibody cocktail from Regeneron Pharmaceuticals famously used to treat former U.S. President Donald Trump in October 2020 have already received emergency use authorization (EUA) as a therapeutic for those who have become infected and are at high risk of developing severe COVID-19. So far, they are not widely used ....

United States , South Africa , San Diego , Davey Smith , Jon Cohen , Eli Lilly , Louisa Perreault , Myron Cohen , Eli Lilly Janelle Sabo , Craigf Walker , Rajesh Gandhi , Heising Simons Foundation , Regeneron Pharmaceuticals , University Of California , Drug Administration , Pulitzer Center , University Of North Carolina School Medicine , Boston Globe , Getty Images , Donald Trump , Massachusetts General , Janelle Sabo , North Carolina School , ஒன்றுபட்டது மாநிலங்களில் , சான் டியாகோ , டேவி ஸ்மித் ,